SCHEMBL7510934

SCHEMBL7510934

CCCCNc1nc(SCCC)nc2c1nnn2C1C[C@H](C(=O)NC(CCC(N)=O)C(=O)NC)C(O)C1O

nearest known ligand 0.71

Predicted protein targets (top 1)

geneUniProtsupporting neighboursconfidence
▸ P2RY12 Q9H244 19/20 0.71

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7510931 1.00 P2RY12 (0.71) P2RY12
SCHEMBL7509805 0.94 P2RY12 (0.74) P2RY12
SCHEMBL7516409 0.90 P2RY12 (0.71) P2RY12
SCHEMBL7510774 0.87 P2RY12 (0.77) P2RY12
SCHEMBL7509267 0.87 P2RY12 (0.77) P2RY12
SCHEMBL7510797 0.86 P2RY12 (0.80) P2RY12
SCHEMBL7515342 0.85 P2RY12 (0.57) P2RY12
SCHEMBL7505979 0.85 P2RY12 (0.79) P2RY12
SCHEMBL7509195 0.84 P2RY12 (0.81) P2RY12
SCHEMBL7508358 0.83 P2RY12 (0.76) P2RY12

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0946561-B1 TRIAZOLO(4,5-D)PYRIMIDINYL DERIVATIVES AND THEIR USE AS MEDICAMENTS ASTRAZENECA AB (SE) 2002-02-13 — — EP claimed
US-6297232-B1 TREATMENT OF PLATELET AGGREGATION DISORDERS. ASTRAZENECA AB (SE) 2001-10-02 — — US claimed
EP-0946561-B1 TRIAZOLO(4,5-D)PYRIMIDINYL DERIVATIVES AND THEIR USE AS MEDICAMENTS ASTRAZENECA AB (SE) 2002-02-13 — — EP disclosed
US-6297232-B1 TREATMENT OF PLATELET AGGREGATION DISORDERS. ASTRAZENECA AB (SE) 2001-10-02 — — US disclosed
Send feedback